Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Vaccines
  3. RSV (Arexvy)

RSV (Arexvy)

RSV9,330 total reports
Share

Manufacturers:

GlaxoSmithKlinePfizer / WyethUnknown ManufacturerModerna

RSV (Arexvy) has 9,330 reports in VAERS spanning from 1990 to 2026. Of these reports, 79 mentioned death, 661 involved hospitalization, and 784 required emergency department visits. This vaccine is manufactured by: GlaxoSmithKline, Pfizer / Wyeth, Unknown Manufacturer, Moderna. This vaccine accounts for 0.5% of all 1,983,260 reports in the VAERS database.

9,330
Total Reports
79
Deaths
661
Hospitalizations
784
ER Visits
170
Disabilities

About RSV (Arexvy)

RSV (Arexvy) has 9,330 reports in VAERS spanning from 1990 to 2026.

Of these reports, 79 mentioned death, 661 involved hospitalization, and 784 required emergency department visits.

This vaccine is manufactured by: GlaxoSmithKline, Pfizer / Wyeth, Unknown Manufacturer, Moderna.

This vaccine accounts for 0.5% of all 1,983,260 reports in the VAERS database.

Reporting Rate

This vaccine averages 2,333 reports per year over 4 years of reporting (2023–2026).

Understanding These Numbers

•Reports don't prove causation. They represent temporal associations where someone experienced an event after vaccination.
•Background rates matter. Many conditions occur naturally and may coincidentally happen after vaccination.
•Reporting varies by vaccine. Newer vaccines or those in the news may have higher reporting rates due to increased awareness.

Most Reported Symptoms

1. Extra dose administered(all)
1,203
2. Injection site pain(all)
1,002
3. Injection site erythema(all)
862
4. Exposure during pregnancy(all)
814
5. No adverse event(all)
806
6. Pain in extremity(all)
788
7. Pain(all)
771
8. Fatigue(all)
745
9. Injection site swelling(all)
700
10. Headache(all)
680

Top Reporting States

1. Florida896
2. California630
3. Texas385
4. New York351
5. Pennsylvania314
6. Georgia293
7. Ohio275
8. North Carolina261

Reports by Year

202617
20252,015
20243,765
20233,044

Explore Further

⚖️ Compare RSV with OthersRead Analysis Articles

Related Analysis

The Denominator ProblemUnderstanding Reporting BiasWhen Do Side Effects Start?Death Reports Deep DiveSerious Outcomes AnalysisMost Common Symptoms

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.